Treatment of liver disorders by administration of RAP conjugates
US8795627B2 · kind B2 · utility
10Cited by
13References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2007 |
| Grant date | Aug 5, 2014 |
| Priority date | — |
| Expiry date | Jan 7, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of receptor-associate protein (RAP) and fragments and variants thereof to improve delivery of therapeutic compounds to the liver and provides methods to treat liver disorders and conditions, such as hepatic carcinoma, by administering RAP or RAP variants conjugated to active agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.